Last Updated : Nov 03, 2020 08:42 PM IST | Source: PTI

COVID-19 woes: 155 non-BFSI firms listed on BSE post Rs 4.39 lakh crore revenue loss in June quarter

According to the report, 45 of the BSE-200 companies operating in BFSI sectors saw muted growth in revenue in the form of lower interest earned on loans by banks and NBFCs as a result of de-growth in loan disbursements in the June quarter.

PTI
Representative image
Representative image

As many as 155 top non-BFSI companies listed on the BSE together reported a revenue loss of Rs 4.39 lakh crore in the June quarter as the coronavirus pandemic and resulting macroeconomic factors impacted business, according to a report.

Leading consultancy EY India's report, released on Tuesday, is based on an analysis of the June quarter reporting compared to that of the March quarter of top 200 BSE listed companies across 13 sectors.

BFSI stands for banking, financial services and insurance. The report evaluated the impact of COVID-19 disruptions on the companies' reporting calendar, profitability, financial performance, liquidity, disclosures and other key parameters.

"155 BSE 200 companies which operate in non-BFSI sectors noted Rs 4,39,714 crore (-30 percent on average) revenue loss in the June 2020 quarter compared to the preceding March 2020 quarter due to the pandemic and resulting changes in macro-economic factors," EY said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

related news

As per the analysis, most of the companies across sectors experienced a material impact on some if not all key financial performance indicators, such as EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), revenue, interest service coverage, profitability as well as Earnings Per Share (EPS).

"Life sciences was the only sector witnessing marginal growth in revenue in the June 2020 quarter compared to the preceding quarter. "However, few sectors reported increase in EBITDA despite revenue loss due to the adoption of cost conservation measures and changes in other macro-economic factors," the report said.

According to the report, 45 of the BSE-200 companies operating in BFSI sectors saw muted growth in revenue in the form of lower interest earned on loans by banks and NBFCs as a result of de-growth in loan disbursements in the June quarter.

"The new business premiums have been impacted for life insurance companies except for protection products. However, for general insurance companies, there is an increase in average net written premium of 37 percent mainly due to the increase in premium for health, fire and crop segments.

"For listed asset management companies, there is an increase in asset under management mainly on account of growth in digital subscriptions and higher subscriptions for gold funds," it said. The 13 sectors covered include advanced manufacturing and mobility, aviation, consumer products and retail, power, real estate and infrastructure.

Jalpa Sonchhatra, Partner, Financial Accounting Advisory Services (FAAS) at EY India said that while analysing the average deferral (number of days) in declaring results for the 2020 June quarter compared to the year-ago period, almost 83 percent companies could declare their results in time without opting for extension awarded by Sebi, compared to 52 percent in March 2020.

"This shows significant improvement and adoption of new normal by most of the companies for their financial closings through intervention of advanced technologies along with an enormous shift in behavioural changes," Sonchhatra added.

Follow our full coverage of the coronavirus pandemic here.
First Published on Nov 3, 2020 08:43 pm